Exercise in Treatment Resistant Depression (TRD): A Feasibility Study
Clinical and Neuroendocrine/Metabolic Benefits of Exercise in Treatment Resistant Depression (TRD): A Feasibility Study
1 other identifier
interventional
21
1 country
1
Brief Summary
The objective of this study is to determine the effects of adjunct exercise in treatment resistant depression. The central hypothesis for the research is that adjunct exercise with usual care in Treatment Resistant Depression (TRD) will have significant effects in improving the psychiatric symptoms in comparison to usual care alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 23, 2011
CompletedFirst Posted
Study publicly available on registry
June 28, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedMarch 6, 2014
March 1, 2014
2 years
June 23, 2011
March 5, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline on Hamilton Rating Scale for Depression-17 item (HRSD17)score
Hamilton Rating Scale for Depression-17 item (HRSD17, a well standardized measure of depression will be the primary measures of efficacy.
Baseline, 6 weeks, and 12 weeks
Secondary Outcomes (3)
Reduction in baseline scores of clinical global impression severity
Baseline, 6 weeks, and 12 weeks
Change from baseline on Beck Depression Inventory-II score
Baseline, 6 weeks, 12 weeks
Change from baseline on Pittsburgh Sleep Quality Index (PSQI) global sleep quality score
baseline, 6 weeks, 12 weeks.
Study Arms (2)
Moderate Intensity Aerobic Exercise
ACTIVE COMPARATORWait List/Usual Care
OTHERThe subjects in this group will continue to receive the usual treatment that they were on at the time of enrollment through the wait list period of 12 weeks. Subsequently they will receive the 12 weeks of aerobic exercise program intervention
Interventions
Individuals in this group will receive moderate intensity exercise in addition to their usual care (Medications+/-Psychotherapy). The moderate intensity exercise program will involve gradual progression in exercise intensity and duration. During the first 4 weeks, participants will attend 3 supervised sessions/week and will be asked to complete at least 2 unsupervised aerobic exercise sessions/week. From weeks 5-8 the number of supervised sessions will be 2/week with at least 3 unsupervised aerobic exercise sessions/week. From weeks 9-12, the participants will have only 1 supervised session/week and will be asked to complete at least 4 unsupervised aerobic exercise sessions/week. In total, the participants will be required to complete 150 minutes of moderate physical activity/week.
The wait list/usual care group will continue with their usual standard treatment (Medications +/- Psychotherapy) as before.
Eligibility Criteria
You may qualify if:
- Being sedentary (exercising less than 3 times/week for \> 20 minutes at moderate/vigorous intensity for each bout)
- Ability to come for supervised exercises up to 5 days/week.
- On stable doses of medication or psychotherapy (within last 1 month) for underlying depression and willingness to continue on stable dose or therapy schedule during active phase of study participation, with the exception of during acute exacerbation of symptoms of psychiatric illness.
- Being able to read, understand, and provide written informed consent.
You may not qualify if:
- DSM-IV TR Axis I diagnosis of bipolar disorder, schizophrenia or schizophrenia spectrum disorder, or substance or alcohol abuse/dependence disorder (except nicotine dependence) in the past 12 months. Patients with current primary anxiety disorder will also be excluded.
- Behavioral or personality disturbances, which may significantly interfere with study participation.
- Evidence of acute suicidal risk.
- Medical contraindication for physical exercise (significant orthopedic or cardiopulmonary disorder) that would prevent regular aerobic exercise. The American College of Sports Medicine criteria for risk stratification will be used and where indicated medical clearance for exercise will be obtained through the subject's primary care physician.
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Milton S. Hershey Medical Centerlead
- Penn State Universitycollaborator
Study Sites (1)
Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ravi Singareddy, MD
Penn State Univ. College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Proffesor
Study Record Dates
First Submitted
June 23, 2011
First Posted
June 28, 2011
Study Start
June 1, 2011
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
March 6, 2014
Record last verified: 2014-03